
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17177376
[patent_doc_number] => 11154605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Vaccine comprising
[patent_app_type] => utility
[patent_app_number] => 16/620846
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 6
[patent_no_of_words] => 17968
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620846
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620846 | Vaccine comprising | Jun 6, 2018 | Issued |
Array
(
[id] => 17904362
[patent_doc_number] => 11458196
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Composition, preparation method and evaluation of a complex immunogen named I-SPGA for production of immunological active proteins (IAP)
[patent_app_type] => utility
[patent_app_number] => 16/620100
[patent_app_country] => US
[patent_app_date] => 2018-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 9158
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620100
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620100 | Composition, preparation method and evaluation of a complex immunogen named I-SPGA for production of immunological active proteins (IAP) | Jun 4, 2018 | Issued |
Array
(
[id] => 16961574
[patent_doc_number] => 20210213073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => APPLICATION OF B. FRAGILIS OR AKKERMANSIA MUCINIPHILA IN PREPARATION OF DRUG FOR PREVENTING OR TREATING TUMOR
[patent_app_type] => utility
[patent_app_number] => 17/054836
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054836
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054836 | APPLICATION OF B. FRAGILIS OR AKKERMANSIA MUCINIPHILA IN PREPARATION OF DRUG FOR PREVENTING OR TREATING TUMOR | May 31, 2018 | Abandoned |
Array
(
[id] => 17712310
[patent_doc_number] => 11376289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Composition and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/059884
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 14163
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059884 | Composition and uses thereof | May 30, 2018 | Issued |
Array
(
[id] => 18151452
[patent_doc_number] => 11564399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Method of producing
[patent_app_type] => utility
[patent_app_number] => 16/615904
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8966
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615904
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615904 | Method of producing | May 30, 2018 | Issued |
Array
(
[id] => 13425111
[patent_doc_number] => 20180264098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => MODULATION OF REPLICATIVE FITNESS BY DEOPTIMIZATION OF SYNONYMOUS CODONS
[patent_app_type] => utility
[patent_app_number] => 15/994074
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994074
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/994074 | Modulation of replicative fitness by deoptimization of synonymous codons | May 30, 2018 | Issued |
Array
(
[id] => 13586571
[patent_doc_number] => 20180344834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => IMMUNOGENIC PROTEINS AGAINST CLOSTRIDIUM DIFFICILE
[patent_app_type] => utility
[patent_app_number] => 15/992497
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15992497
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/992497 | Immunogenic proteins against clostridium difficile | May 29, 2018 | Issued |
Array
(
[id] => 18887948
[patent_doc_number] => 11866712
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => System based on the reassembly of GFP for studying the trans-translational activity and identifying new antibiotics
[patent_app_type] => utility
[patent_app_number] => 17/056574
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17462
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056574
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056574 | System based on the reassembly of GFP for studying the trans-translational activity and identifying new antibiotics | May 24, 2018 | Issued |
Array
(
[id] => 13410317
[patent_doc_number] => 20180256701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => PSEUDOMONAS ANTIGENS AND ANTIGEN COMBINATIONS
[patent_app_type] => utility
[patent_app_number] => 15/977901
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15977901
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/977901 | PSEUDOMONAS ANTIGENS AND ANTIGEN COMBINATIONS | May 10, 2018 | Abandoned |
Array
(
[id] => 16353122
[patent_doc_number] => 10793623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Optimized crosslinkers for trapping a target on a substrate
[patent_app_type] => utility
[patent_app_number] => 15/977432
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 83
[patent_no_of_words] => 38588
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15977432
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/977432 | Optimized crosslinkers for trapping a target on a substrate | May 10, 2018 | Issued |
Array
(
[id] => 16837941
[patent_doc_number] => 20210145953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => ATTENUATION SYSTEM AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/050771
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050771
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050771 | Attenuation system and use thereof | Apr 25, 2018 | Issued |
Array
(
[id] => 18375981
[patent_doc_number] => 20230151063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => MULTIVALENT OSPA POLYPEPTIDES AND METHODS AND USES RELATING THERETO
[patent_app_type] => utility
[patent_app_number] => 16/497178
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497178
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497178 | Multivalent OspA polypeptides and methods and uses relating thereto | Apr 12, 2018 | Issued |
Array
(
[id] => 14143173
[patent_doc_number] => 10251938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Angiopoietin-based interventions for treating cerebral malaria
[patent_app_type] => utility
[patent_app_number] => 15/949472
[patent_app_country] => US
[patent_app_date] => 2018-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 29
[patent_no_of_words] => 8517
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15949472
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/949472 | Angiopoietin-based interventions for treating cerebral malaria | Apr 9, 2018 | Issued |
Array
(
[id] => 16599357
[patent_doc_number] => 20210025888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => CRUDE NATIVE HAPTEN-BASED INDIRECT ELISA ASSAY KIT AND LYOPHILISED CONTROLS FOR THE CONFIRMATORY DIAGNOSIS OF BOVINE BRUCELLOSIS IN BLOOD SERUM AND MILK BY ANIMAL AND TANK
[patent_app_type] => utility
[patent_app_number] => 16/603019
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603019
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603019 | Crude native Hapten-based indirect ELISA assay KIT and lyophilised controls for the confirmatory diagnosis of bovine brucellosis in blood serum and milk by animal and tank | Apr 4, 2018 | Issued |
Array
(
[id] => 13339855
[patent_doc_number] => 20180221467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => GLYCOCONJUGATION PROCESSES AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/946664
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946664
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946664 | Glycoconjugation processes and compositions | Apr 4, 2018 | Issued |
Array
(
[id] => 13733273
[patent_doc_number] => 20180371104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life
[patent_app_type] => utility
[patent_app_number] => 15/946034
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946034
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946034 | Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life | Apr 4, 2018 | Abandoned |
Array
(
[id] => 16087025
[patent_doc_number] => 20200197499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => Yeast-Based Immunotherapy for Tumour Prevention
[patent_app_type] => utility
[patent_app_number] => 16/500179
[patent_app_country] => US
[patent_app_date] => 2018-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500179
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500179 | Yeast-Based Immunotherapy for Tumour Prevention | Apr 3, 2018 | Abandoned |
Array
(
[id] => 17050742
[patent_doc_number] => 20210260176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => Methods and Compositions for Vaccinating Against Malaria
[patent_app_type] => utility
[patent_app_number] => 16/497244
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497244
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497244 | Methods and Compositions for Vaccinating Against Malaria | Mar 29, 2018 | Abandoned |
Array
(
[id] => 13326007
[patent_doc_number] => 20180214541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => Haemophilus influenzae fusion protein and construction method and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/940871
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15940871
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/940871 | None | Mar 28, 2018 | Issued |
Array
(
[id] => 13328549
[patent_doc_number] => 20180215812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => PEPTIDES AND BINDING PARTNERS THEREFOR
[patent_app_type] => utility
[patent_app_number] => 15/933660
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15933660
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/933660 | PEPTIDES AND BINDING PARTNERS THEREFOR | Mar 22, 2018 | Abandoned |